Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling (2013)
- Authors:
- USP affiliated authors: COSTA NETO, CLAUDIO MIGUEL DA - FMRP ; GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FMRP; FORP
- DOI: 10.1016/j.ijcard.2012.03.137
- Subjects: ANGIOTENSINA II; HIPERTENSÃO; METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Cardiology
- ISSN: 0167-5273
- Volume/Número/Paginação/Ano: v. 167, n. 4, p. 1199-1205, 2013
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
- Licença: publisher-specific-oa
-
ABNT
MARTINS-OLIVEIRA, Alisson et al. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, v. 167, n. 4, p. 1199-1205, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2012.03.137. Acesso em: 19 set. 2024. -
APA
Martins-Oliveira, A., Castro, M. M. de, Oliveira, D. M. M., Rizzi, E., Ceron, C. S., Guimarães, D., et al. (2013). Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, 167( 4), 1199-1205. doi:10.1016/j.ijcard.2012.03.137 -
NLM
Martins-Oliveira A, Castro MM de, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM da, Casarini DE, Ribeiro AA, Gerlach RF, Tanus-Santos JE. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137 -
Vancouver
Martins-Oliveira A, Castro MM de, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM da, Casarini DE, Ribeiro AA, Gerlach RF, Tanus-Santos JE. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137 - Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
- Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism
- Determinação de gelatinases no fluido gengival em pacientes sadios e com doença periodontal
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
Informações sobre o DOI: 10.1016/j.ijcard.2012.03.137 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas